answering body |
Department of Health and Social Care |
|
|
question text |
To ask Her Majesty's Government, further to the Written Answers by the Parliamentary
Under-Secretary of State for Health on 14 July 2014 (HC Deb, col 448W), Earl Howe
on 3 December 2014 (HL273), and comments by the Parliamentary Under-Secretary of State
for Health on 20 January 2016 (HC Deb, col 623WH), how the Human Fertilisation and
Embryology Authority (HFEA) ensures that clinics follow National Institute for Health
and Care Excellence guidelines on limiting the use of ovulation induction or ovarian
stimulation agents to the lowest effective dose and duration of use without collecting
information on the identity of drugs used in treatment, the dosage used and the associated
regimen for ovarian stimulation at each licensed centre; and what would be needed
for the HFEA to regulate the administration of drugs during in vitro fertilisation
treatment.
|
|